Cell Therapies and Bioengineering Conference

September 20-22, 2018

We are excited to present the first conference on Cell Therapies and Bioengineering. This conference will highlight new and upcoming research in this field such as CAR T cell therapies, TCR T cells, Immune cells other than conventional T cells, challenges and opportunities for cell therapies for solid tumors, synthetic biology for cellular immunotherapy, and much more!

Registration Info Here

Conference Flyer

Industry Panel:

  • Justin Farlow, Co-Founder, Serotiny, Inc.
  • Brian Garrison, Group Leader: Cell Technologies, Senti Bio
  • Ryan Pawell, CEO, Indee Labs
  • Elizabeth Wood, Co-Founder, JURA Bio
  • Julie Norville, Co-Founder, JURA Bio

Keynote Speakers:

Invited Speakers:

Session Topics:

1. CD19 Story: What Has Worked, and Lessons Learned From the Success of CAR T cell Therapy

2. Challenges and Opportunities for Cell Therapies for Solid Tumors (Antigens, Metabolism, and the Tumor Microenvironment)

3. Genome Editing for Therapeutic Cell Engineering: Efficacy vs Safety

4. Industry Session: Panel

5. Immunotherapy: Immune Cells other than Conventional T cells

6. Synthetic Biology for Cellular Immunotherapy

7. Novel Delivery Technology for Cell Therapies

8. TCR T cells

9. Understanding and Engineering Persistence

Conference Co-Chairs:

Organizing Committee:

Featured Speakers

Adrian Bot

Dr. Adrian Bot, M.D., Ph.D. served as a Vice President of Translation Medicine at Kite Pharma, Inc. until October 2, 2017. Dr. Bot served as a Vice President of Scientific Affairs at Kite Pharma, Inc. and served as its Chief Scientific officer.Read more

Justin Farlow

Dr. Farlow cofounded and is the CTO of Serotiny.  Serotiny designs custom multi-domain proteins for use in cell therapies.  Justin received his doctorate from the UCSF in 2014.  He worked in Zev Gartner’s lab to study the biophysics of Notch receptors in live cells.  More generally, his work aimed to investigate the communication between different cell types in topologically-defined cellular microenvironments.

At Serotiny, Justin built a digital infrastructure to manage, design, and predict the functionality of synthetic proteins constructed from multiple protein...Read more

Amy Gilbert

Amy Gilbert, Ph.D. is a Director in the cell therapy research organization at Kite Pharma, A Gilead company.  Amy received her B.A. in biology from Middlebury College and completed her Ph.D. in Immunology at the National Institute for Health Research Biomedical Research Centre at King’s College London.  There she studied novel therapeutic approaches to activate innate and adaptive immune responses in melanoma.  Prior to joining Kite Pharma, Amy hold 10+ years of experience in the biotechnology field working at Genentech, Amgen and more recently at Cell Design Labs....Read more

Michael Goldberg

Dr. Goldberg received his PhD in 2008 from MIT, where he worked in the laboratory of Institute Professor Robert Langer. He subsequently pursued post-doctoral training under the supervision of Institute Professor Philip Sharp at MIT.Read more

Giedre Krenciute

Giedre Krenciute is a junior faculty member in the Department of Bone Marrow Transplantation and Cellular Therapy at St Jude Children’s Research Hospital. She received her PhD in Biochemistry and Molecular Biology at Baylor College of Medicine (BCM), followed by post-doctoral training in the Center for Cell and Gene Therapy at BCM. The major focus of her laboratory is to develop an effective immunotherapy for gliomas using genetically modified T cells. Research areas include generating and optimizing CAR T-cells to target glioma associated antigens, enhancing CAR T cell effector functions...Read more

Timothy Lu

Timothy K. Lu, M.D., Ph.D. is an Assistant Professor leading the Synthetic Biology Group in the Department of Electrical Engineering and Computer Science and Department of Biological Engineering at MIT. Tim has pioneered new approaches to combat infectious diseases with synthetic biology, encode memory in the DNA of living cells, and perform both digital and analog computation in biological systems.Read more

Alexander Marson

Alex Marson completed medical school at Harvard, PhD training at the Whitehead Institute/MIT with Richard Young and Rudolf Jaenisch, Internal Medicine residency at the Brigham and Women’s and clinical training in Infectious Diseases at UCSF.Read more

Garry Nolan

Dr. Nolan is the Rachford and Carlota A. Harris Professor in the Department of Microbiology and Immunology at Stanford University School of Medicine. He trained with Leonard Herzenberg (for his Ph.D.) and Nobelist Dr. David Baltimore (for postdoctoral work for the first cloning/characterization of NF-κB p65/ RelA and the development of rapid retroviral production systems).Read more

Cliona Rooney

Cliona Rooney, PhD, Professor is a Full Professor in the Center of Cell and Gene Therapy (CAGT), the Department of Pediatrics, the Department of Molecular Virology Microbiology and the Department of Pathology-Immunology at Baylor College of Medicine.Read more

Kole Roybal

Dr. Roybal is an Assistant Professor in the Department of Microbiology and Immunology at the University of California, San Francisco. He is a full member of the Parker Institute for Cancer Immunotherapy and an inaugural Chan Zuckerberg Biohub investigator.Read more

Matthias Stephan

Dr. Stephan’s laboratory in the Clinical Research Division at Fred Hutchinson Cancer Research Center works at the interface of materials science and immunology, designing synthetic materials that can be used as components of novel cancer immunotherapies.Read more

Li Tang

Dr. Li Tang is currently an Assistant Professor and Principal Investigator for the Laboratory of Biomaterials for Immunoengineering (LBI) at École polytechnique fédérale de Lausanne (EPFL). Dr. Li Tang was an Irvington Postdoctoral Fellow in Dr. Darrell Irvine’s lab at MIT.Read more

Qizhi Tang

Qizhi Tang, PhD, is professor in immunology and director of the UCSF Transplantation Research Laboratory, where she leads basic and translational research in transplantation immunology.  Research in the Tang Lab has two major focus areas:

1)   Investigating regulatory T cell control of autoimmune diseases and transplant rejection and their therapeutic applications in these disease settings. The Tang lab has shown that infusion of regulatory T cells can reverse type 1 diabetes and prevent rejection of transplanted islets in animal models....Read more

Cameron Turtle

Cameron Turtle is an Attending Physician on the Fred Hutch Bone Marrow Transplant Program and the Immunotherapy Service at the Seattle Cancer Care Alliance (SCCA), a cancer treatment center that unites doctors from Fred Hutch, University of Washington Medicine and Seattle Children’s Hospital. He received his MBBS from the University of Sydney, and his Ph.D. from the University of Queensland.Read more

Xiaoping Zhong

The immune system protects the host from microbial infection but can cause diseases if not properly controlled. My lab is interested in the receptor signaling mediated regulation of immune cell development and function as well as the pathogenesis and treatment of autoimmune diseases and allergies.Read more